Document is current
Any future updates will be listed below
-
Authors
,
de Velde, Femke http://orcid.org/0000-0003-4581-9688
de Winter, Brenda C. M.
Neely, Michael N.
Yamada, Walter M.
Koch, Birgit C. P.
Harbarth, Stephan
von Dach, Elodie
van Gelder, Teun
Huttner, Angela
Mouton, Johan W.
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (115523)
Université de Genève (PRD 09-II-025)
FP7 Science in Society (Health-F3-2011-278348)
- License Information
-
More Information
Article History
First Online: 20 January 2020
Compliance with Ethical Standards
:
: This work was supported by the Innovative Medicines Initiative Joint Undertaking under Grant agreement no. 115523, the resources of which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in-kind contribution. The research leading to these results was conducted as part of the COMBACTE-NET consortium. For further information please refer to . The initial cohort study was funded by a research and development Grant awarded by the Geneva University Hospitals in 2009 (PRD 09-II-025). AH and EvD were partially supported by the EU-funded project AIDA (Grant Health-F3-2011-278348).
: Femke de Velde, Brenda de Winter, Michael Neely, Walter Yamada, Elodie von Dach and Angela Huttner declare they have no conflicts of interest. Johan Mouton has received research funding from IMI, the EU, ZonMw (Dutch governmental support), Adenium, AstraZeneca, Basilea, Eumedica, Cubist, Merck & Co., Pfizer, Polyphor, Roche, Shionogi, Thermo-Fisher, Wockhardt, Astellas, Gilead and Pfizer. Birgit Koch has received research funding from ZonMw (Dutch governmental support) and Teva. Stephan Harbarth has received honoraria from Sandoz for participation in a Scientific Advisory Board. Teun van Gelder has received honoraria as a consultant/speaker from Aurinia Pharma, Vitaeris, Roche Diagnostics, Novartis, Astellas and Chiesi, along with grant support for transplant-related studies from Chiesi and Astellas.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Geneva University Hospital’s Ethics Committee, NAC 09-117) and with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from individual participants included in this study, unless patients were unconscious or otherwise unable to understand the study protocol. This was approved by the abovementioned Ethics Committee, given the observational nature of the study.
